300434 logo

Sichuan Goldstone Asia Pharmaceutical Inc. Stock Price

SZSE:300434 Community·CN¥4.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300434 Share Price Performance

CN¥10.06
2.94 (41.29%)
CN¥10.06
2.94 (41.29%)
Price CN¥10.06

300434 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

1 Risk
2 Rewards

Sichuan Goldstone Asia Pharmaceutical Inc. Key Details

CN¥1.1b

Revenue

CN¥440.1m

Cost of Revenue

CN¥614.1m

Gross Profit

CN¥483.7m

Other Expenses

CN¥130.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
0.32
58.25%
12.37%
4.9%
View Full Analysis

About 300434

Founded
1962
Employees
1937
CEO
Yiping Ma
WebsiteView website
www.goldstone-group.com

Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. The company offers over-the-counter drugs, prescription drugs, raw materials and health foods. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company produces, installs, and maintains special equipment. It also imports and exports spare parts, raw, and auxiliary materials. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 1962 and is based in Hangzhou, China.

Recent 300434 News & Updates

Recent updates

No updates